Skip to main content

Table 1 The clinicopathologic characteristics of the training and validation sets

From: Nomogram for individually predicting overall survival in rectal neuroendocrine tumours

Variable

Training Set

(n = 310)

Validation Set

(n = 547)

No. of patients

%

No. of patients

%

Median age (years)

49.1 ± 13.6

 

58.7 ± 13.1

 

Sex

 Male

195

62.9

276

50.5

 Female

115

37.1

271

49.5

Surgical treatment

 Endoscopic resection

139

44.8

 Transanal excision

50

16.1

 Radical resection

89

28.7

 No surgical treatment

33

10.6

Tumour Size (cm)

< 2

250

80.6

286

52.3

2–4

28

9.0

98

17.9

> 4

32

10.3

163

29.8

G classification

 G1

235

75.8

226

41.3

 G2

45

14.5

59

10.8

 G3

30

9.7

262

47.9

T Staging

 T1

231

74.5

303

55.2

 T2

38

12.3

81

14.8

 T3

31

10.0

100

18.3

 T4

10

3.2

64

11.7

N Staging

 N0

264

85.2

353

64.7

 N1

46

14.8

194

35.3

M Staging

 M0

277

89.4

423

77.3

 M1

33

10.6

124

22.7

TNM Staging

I

220

71.0

267

48.8

II

31

10.0

48

8.8

III

26

8.4

108

19.7

IV

33

10.6

124

22.7

  1. TNM Tumour node metastasis